期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 16, 期 2, 页码 683-691出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2007.10.042
关键词
-
资金
- NIAID NIH HHS [AI46365] Funding Source: Medline
- NIGMS NIH HHS [R01 GM061587, GM61587] Funding Source: Medline
The key dinitrile intermediates 4a-d were synthesized by reaction of phenacyl bromide 1 and the appropriate 2-amino-5-bromopyridines to yield 3a-d. Suzuki coupling of 3a-d with 4-cyanophenylboronic acid yielded the 2,6-bis(4-cyanophenyl)-imidazo[1,2-a]pyridine derivatives 4a-d. The bis-amidoximes 5a-d, obtained from 4a-d by the action of hydroxylamine, were converted to the bis-O-acetoxyamidoximes which on catalytic hydrogenation in a mixture of ethanol/ethyl acetate gave the acetate salts or 2,6-bis[4-(amidinophenyl)]-imidazo[1,2-a]pyridines 7a-d, In contrast, catalytic hydrogenation of the bis-O-acetoxyamidoxime of 5a in glacial acetic acid gave the saturated analogue 2,6-bis[4-(amidinophenyl)]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine8. 0-Methylation of the amidoximes 5a-d gave the N-methoxyamidines 6a-d. The diamidines showed strong DNA binding affinity, were very active in vitro against T. b. r. exhibiting IC50 values between 7 and 38 nM, but were less effective against P. f with IC50 values between 23 and 92 nM. Two of the diamidines 7c and 7d were slightly more active than furamidine but less active than azafuramidine in the T b. r. STIB900 mouse model. Only one prodrug 6b showed moderate activity in the same mouse model. (c) 2007 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据